Mátyás Keltai

2 ta ish

Semmelweis University

1. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

   Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais +97

   MaqolaOAOchiq kirish20192 iqtibos

   ABIABI:AkademIndex/2026.other.057761

2. Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease

   Salim Yusuf, Eva Lonn, Prem Pais +29

   Maqola20162 iqtibos

   ABIABI:AkademIndex/2026.other.295802